N. Lander

1.3k total citations
20 papers, 948 citations indexed

About

N. Lander is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, N. Lander has authored 20 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 7 papers in Cellular and Molecular Neuroscience and 6 papers in Organic Chemistry. Recurrent topics in N. Lander's work include Cannabis and Cannabinoid Research (14 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Neuroscience and Neuropharmacology Research (2 papers). N. Lander is often cited by papers focused on Cannabis and Cannabinoid Research (14 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Neuroscience and Neuropharmacology Research (2 papers). N. Lander collaborates with scholars based in Israel, United States and Sweden. N. Lander's co-authors include Raphael Mechoulam, E.A. Carlini, Oswaldo L. Ramos, Rubens José Gagliardi, Wilson Luíz Sanvito, Torbjörn U.C. Järbe, Arto J. Hiltunen, J. J. Feigenbaum, Paul Consroe and Zvi Ben‐Zvi and has published in prestigious journals such as Brain Research, Journal of Medicinal Chemistry and Cellular and Molecular Life Sciences.

In The Last Decade

N. Lander

19 papers receiving 902 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Lander Israel 11 784 421 146 135 125 20 948
BR Martin United States 11 940 1.2× 609 1.4× 124 0.8× 145 1.1× 210 1.7× 16 1.0k
Tzviel Sheskin Israel 6 787 1.0× 311 0.7× 177 1.2× 107 0.8× 110 0.9× 6 903
B R Martin United States 17 1.0k 1.3× 636 1.5× 83 0.6× 122 0.9× 327 2.6× 28 1.2k
Alexandros Makriyannis United States 14 545 0.7× 361 0.9× 69 0.5× 81 0.6× 112 0.9× 25 691
Séverine Vandevoorde Belgium 18 1.1k 1.4× 341 0.8× 178 1.2× 112 0.8× 140 1.1× 21 1.3k
E. W. Gill United Kingdom 16 422 0.5× 326 0.8× 86 0.6× 68 0.5× 101 0.8× 36 948
Sonyuan Lin United States 13 1.1k 1.5× 727 1.7× 157 1.1× 153 1.1× 216 1.7× 16 1.3k
Javier Corchero Spain 21 1.1k 1.4× 890 2.1× 60 0.4× 216 1.6× 97 0.8× 27 1.7k
R K Razdan United States 8 984 1.3× 603 1.4× 180 1.2× 145 1.1× 219 1.8× 11 1.1k
Guillermo Moreno‐Sanz United States 17 822 1.0× 280 0.7× 107 0.7× 134 1.0× 119 1.0× 26 1.0k

Countries citing papers authored by N. Lander

Since Specialization
Citations

This map shows the geographic impact of N. Lander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Lander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Lander more than expected).

Fields of papers citing papers by N. Lander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Lander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Lander. The network helps show where N. Lander may publish in the future.

Co-authorship network of co-authors of N. Lander

This figure shows the co-authorship network connecting the top 25 collaborators of N. Lander. A scholar is included among the top collaborators of N. Lander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Lander. N. Lander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mechoulam, Raphael, et al.. (1990). Synthesis of the individual, pharmacologically distinct, enantiomers of a tetrahydrocannabinol derivative. Tetrahedron Asymmetry. 1(5). 315–318. 87 indexed citations
2.
Mechoulam, Raphael, J. J. Feigenbaum, N. Lander, et al.. (1988). Enantiomeric cannabinoids: stereospecificity of psychotropic activity. Cellular and Molecular Life Sciences. 44(9). 762–764. 156 indexed citations
3.
Mechoulam, Raphael, N. Lander, Morris Srebnik, et al.. (1987). Stereochemical Requirements for Cannabimimetic Activity. PsycEXTRA Dataset. 79. 15–30. 27 indexed citations
4.
Järbe, Torbjörn U.C., Arto J. Hiltunen, N. Lander, & Raphael Mechoulam. (1986). Cannabimimetic activity (Δ1-THC cue) of cannabidiol monomethyl ether and two stereoisomeric hexahydrocannabinols in rats and pigeons. Pharmacology Biochemistry and Behavior. 25(2). 393–399. 25 indexed citations
5.
Nathan, Ilana, et al.. (1986). Specific impairment of ADP-induced platelet aggregation by cannabinoids.. PubMed. 8(3). 193–8. 1 indexed citations
6.
Letsinger, Robert L., et al.. (1984). Some developments in the phosphitetriester method for synthesis of oligonucleotides. Tetrahedron. 40(1). 137–143. 45 indexed citations
7.
Edery, H., et al.. (1984). Activity of novel aminocannabinoids in baboons. Journal of Medicinal Chemistry. 27(10). 1370–1373. 10 indexed citations
8.
Nathan, Ilana, et al.. (1982). Cannabinoids and serotonin uptake by blood platelets: Evidence for multiple sites of action. Biochemical Pharmacology. 31(3). 439–441. 6 indexed citations
9.
Carlini, E.A., et al.. (1982). Anticonvulsant Effects of the (–) and (+)Isomers of Cannabidiol and Their Dimethylheptyl Homologs. Pharmacology. 24(3). 141–146. 40 indexed citations
10.
Revuelta, A., D.L. Cheney, E. Costa, N. Lander, & Raphael Mechoulam. (1980). Reduction of hippocampal acetylcholine turnover in rats treated with (−)-Δ8-tetrahydrocannabinol and its 1′,2′-dimethyl-heptyl homolog. Brain Research. 195(2). 445–452. 17 indexed citations
11.
Carlini, E.A., Oswaldo L. Ramos, Rubens José Gagliardi, et al.. (1980). Chronic Administration of Cannabidiol to Healthy Volunteers and Epileptic Patients. Pharmacology. 21(3). 175–185. 400 indexed citations
13.
Mechoulam, Raphael, et al.. (1980). Stereochemical requirements for cannabinoid activity. Journal of Medicinal Chemistry. 23(10). 1068–1072. 50 indexed citations
14.
CORDOVA, T., Daniel Ayalon, N. Lander, et al.. (1980). The ovulation blocking effect of cannabinoids: Structure-activity relationships. Psychoneuroendocrinology. 5(1). 53–62. 6 indexed citations
15.
Mechoulam, Raphael, et al.. (1980). Base‐Catalyzed Conversion of an Equatorial into an Axial Methoxycarbonyl Group Due to a 1,5‐Long‐Range Substituent Effect. Angewandte Chemie International Edition in English. 19(7). 543–543. 7 indexed citations
16.
Lander, N., et al.. (1976). Total synthesis of cannabidiol and delta1-tetrahydrocannabinol metabolites.. PubMed. 8–16. 4 indexed citations
17.
Meyer, Amatzya Y., et al.. (1976). Spectral effects in cyclobutane derivatives. Tetrahedron. 32(22). 2805–2810. 5 indexed citations
18.
Lander, N., et al.. (1976). Total syntheses of cannabidiol and Δ1-tetrahydrocannabinol metabolites. Journal of the Chemical Society Perkin Transactions 1. 8–16. 20 indexed citations
19.
Carlini, E.A., Raphael Mechoulam, & N. Lander. (1975). Anticonvulsant activity of four oxygenated cannabidiol derivatives.. PubMed. 12(1). 1–15. 33 indexed citations
20.
Lander, N., et al.. (1973). Polybarbiturates. Israel Journal of Chemistry. 11(6). 835–840. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026